ArticleEJNMMI physics2021
Gamma camera characterization at high holmium-166 activity in liver radioembolization.
Article in EJNMMI physics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Evolving SPECT-CT technology.The British journal of radiology · 2026Review
- Acute radiotoxicity studies and safety assessment ofScientific reports · 2025Article
- Lung shunting and radiation pneumonitis after holmium-166 TARE: a case study.EJNMMI reports · 2025Article
- Dosimetric study on radioembolization with 166Ho poly L-lactic acid microspheres: dead time effects on prediction power.EJNMMI physics · 2025Article
- Towards harmonized holmium-166 SPECT image quality for dosimetry: a multi-center, multi-vendor study.EJNMMI physics · 2025Article
- Development and validation of an innovative administration system to facilitate controlled holmium-166 microsphere administration during TARE.EJNMMI physics · 2024Article
- Accuracy of holmium-166 SPECT/CT quantification over a large range of activities.EJNMMI physics · 2024Article
- Clinical Results of Holmium-166 Radioembolization with Personalized Dosimetry for the Treatment of Hepatocellular Carcinoma.Journal of personalized medicine · 2024Article
- Dose-effect relationships in neuroendocrine tumour liver metastases treated with [European journal of nuclear medicine and molecular imaging · 2024Article
- Gamma camera imaging characteristics ofEJNMMI physics · 2024Article
- Impact of scatter correction on personalized dosimetry in selective internal radiotherapy usingEJNMMI physics · 2024Article
- Advances in Radionuclides and Radiolabelled Peptides for Cancer Therapeutics.Pharmaceutics · 2023Review
- Holmium-166 Radioembolization: Current Status and Future Prospective.Cardiovascular and interventional radiology · 2022Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundHigh activities of holmium-166 (
resultsA 20% count loss due to dead time was observed around 0.7 GBq in the photopeak window. Independent of the count losses, the measured activity concentration was up to 100% of the real value for non-tumorous liver, when reconstructions were normalized to the known activity at scanning time. However, for tumor spheres, activity concentration recovery was ~80% at the lowest activity, decreasing with increasing activity in the phantom. Measured lung shunt fractions were relatively constant over the considered activity range.
conclusionsAt high
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.